Fairmount advises NWL on its acquisition by American Superconductor (“AMSC”)

Bordentown, NJ – August 1, 2024 – AMSC (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability of our Navy’s fleet, today announced that it has acquired Megatran Industries d/b/a NWL, a manufacturer of highly engineered power conversion products.  […]

Fairmount Partners Advises Clariness on its Merger with SubjectWell to Form Global, Full-Service Patient Recruitment Platform

JANUARY 27, 2026, BERLIN, GERMANY AND AUSTIN, TX, USA: Clariness and SubjectWell announced their merger to form one of the largest global, full-service patient recruitment platforms, combining global scale, scientific rigor, and patient-first design to transform clinical trial access and execution worldwide. The transaction was led by WindRose Health Investors, LLC (“WindRose”), which previously acquired […]

Fairmount Partners Advises Evidinno Outcomes Research on its Sale to UBC – Expanding Real-World Evidence and HEOR Capabilities

The acquisition strengthens UBC’s leadership in evidence generation offerings with globally recognized expertise in HEOR, medical affairs and market access. KING OF PRUSSIA, PA, January 6, 2026 – United BioSource LLC (UBC) today announced it has acquired Evidinno Outcomes Research Inc. (Evidinno), a healthcare research consulting firm headquartered in Vancouver, Canada specializing in real-world evidence […]

Fairmount Partners Advises InSource on its Sale to CoreX – Expanding ServiceNow Delivery Capabilities Across the Americas

Radnor, PA – January 6, 2026 — CoreX, a high-growth Elite Consulting and Implementation Partner of ServiceNow and NewSpring Holdings platform company, today announced the successful completion of its acquisition of InSource’s ServiceNow business unit. InSource is a fellow Elite Partner recognized for deep delivery expertise and an unwavering commitment to client success. The transaction […]

Arlington Capital Partners Announces Majority Growth Investment in CBSET

The partnership will help CBSET scale its integrated preclinical research & testing platform through significant capacity expansion and strategic add-on acquisitions Washington, D.C. – October 3, 2025 – Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, has completed a majority growth investment in Concord Biomedical Sciences and Emerging […]

Ballymore Safety Products Acquires Equipto, a Manufacturer of Engineered Storage Solutions Designed to Maximize Space

COATESVILLE, PA — September 22, 2025. Ballymore Safety Products (“Ballymore” or the “Company”), a portfolio company of One Equity Partners (“OEP”), and a leading designer, manufacturer, and service provider of vertical access equipment (e.g., aerial work platforms, rolling ladders, etc.), material handling, and custom safety products, today announced the completed acquisition of Consolidated Storage Companies, […]

Fairmount Partners Advises The Riverside Company on its Sale of Performance Systems Integration to Summit Fire & Security

September 4, 2025 – The Riverside Company (Riverside), a global investment firm focused on the smaller end of the middle market, has announced the sale of Performance Systems Integration (PSI), the leading regional provider of fire and life safety services in the Pacific Northwest, to Summit Fire & Security LLC (Summit). Transaction terms were not […]

Fairmount Partners Advises NorthEast BioLab on its Sale to Normec

Normec Enters the US with Three Strategic Acquistions: AMSTERDAM & NEW YORK – Normec (“the Group”), a leading European provider of Testing, Inspection, Certification, and Compliance (“TICC”) services, has announced its entry into the United States (“US”) through the acquisition of three highly specialized companies in the Foodcare, Sustainability, and Healthcare sectors. Normec is backed […]

Fairmount Partners Advises FutureMeds, Europe’s Leading Clinical Trial Site Network, on Investment from Phoenix Equity Partners

LONDON, UK – July 29th, 2025: Phoenix Equity Partners (“Phoenix”), the UK private equity firm, focused on partnering with founder-entrepreneurs, is pleased to announce its latest investment in FutureMeds, a group of research sites providing patient recruitment and clinical trial management services across Europe. Phoenix is proud to be partnering with FutureMeds’ three co-founders; Dr […]